Apple, which had been the top smartphone seller in China for several years, fell to third place last year behind Chinese companies such as Vivo and Huawei.

Beam is pursuing a long-term, staged development strategy for sickle cell disease that includes three “waves” of ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

ESCAPE: Beam's wave 2 approach is its Engineered Stem Cell Antibody Evasion (ESCAPE) platform, which aims to provide the same ex vivo-manufactured cell product deployed in wave 1, but now using a ...

But in vivo CAR-Ts are not a far-off pipe dream ... with VivoVec [Umoja’s proprietary viral vector], it'll be manufactured in our facility in Colorado and shipped and stored globally in a ...

Improvements in the latter half of 2024 could continue or even improve in 2025 according to the National Association of ...

Matti Beshay, Head of the Trade Committee at the Importers Division of the Federation of Egyptian Chambers of Commerce ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

Used car sales dipped in December, but new car sales showed promising year-on-year growth. Here’s how South Africa's ...

The Pakistani government is reportedly working to revamp its Local Mobile Device Manufacturing Policy to include tablets and ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...